» Articles » PMID: 2768131

Maintenance of Dihydrofolate Reductase Enzyme After Disappearance of DHFR MRNA During Muscle Cell Differentiation

Overview
Date 1989 Aug 1
PMID 2768131
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Terminally differentiating mouse muscle cells were used to examine the relationship between myogenic withdrawal from the cell cycle and the levels of dihydrofolate reductase (DHFR) mRNA and DHFR activity. Differentiation was induced by removal of fibroblast growth factor activity from the medium. DHFR mRNA was measured by a RNase protection assay. DHFR activity was measured by a spectrophotometric assay and by a [3H]methotrexate binding assay. Proliferative myoblasts contained four DHFR mRNA molecules and 1.8 X 10(5) DHFR enzyme molecules. By 12.5 h after induction, when [3H]thymidine labeling indices showed all cells had withdrawn from the cell cycle, DHFR mRNA levels had declined to 0.7 copies per cell. In contrast, myogenic withdrawal did not result in reduced DHFR activity. Qualitatively similar results, i.e. down-regulation of mRNA and constitutive expression of activity, were observed in a methotrexate-selected muscle cell line with greater than 50-fold amplification of the DHFR gene. Enzyme synthesis rate and stability measurements indicated that persistence of DHFR activity in postreplicative cells was due to a long enzyme lifetime rather than to continued synthesis from residual normal DHFR mRNA or an alternative mRNA species not detected by the RNase protection assay. Unlike DHFR, thymidine kinase (TK) activity disappeared rapidly as muscle cells differentiated. Both DHFR mRNA and TK mRNA are expressed in a replication-dependent manner; however, the enzymes encoded by these messages are subject to different fates in postreplicative cells.

Citing Articles

BAC TG-EMBED: one-step method for high-level, copy-number-dependent, position-independent transgene expression.

Bian Q, Belmont A Nucleic Acids Res. 2010; 38(11):e127.

PMID: 20385594 PMC: 2887973. DOI: 10.1093/nar/gkq178.


Changes in dihydrofolate reductase (DHFR) mRNA levels can account fully for changes in DHFR synthesis rates during terminal differentiation in a highly amplified myogenic cell line.

Schmidt E, Merrill G Mol Cell Biol. 1991; 11(7):3726-34.

PMID: 2046674 PMC: 361140. DOI: 10.1128/mcb.11.7.3726-3734.1991.

References
1.
Slater C . Control of myogenesis in vitro by chick embryo extract. Dev Biol. 1976; 50(2):264-84. DOI: 10.1016/0012-1606(76)90151-2. View

2.
Goldman I, LICHTENSTEIN N, OLIVERIO V . Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J Biol Chem. 1968; 243(19):5007-17. View

3.
Borun T, Scharff M, Robbins E . Rapidly labeled, polyribosome-associated RNA having the properties of histone messenger. Proc Natl Acad Sci U S A. 1967; 58(5):1977-83. PMC: 223893. DOI: 10.1073/pnas.58.5.1977. View

4.
Linkhart T, Clegg C, Hauschika S . Myogenic differentiation in permanent clonal mouse myoblast cell lines: regulation by macromolecular growth factors in the culture medium. Dev Biol. 1981; 86(1):19-30. DOI: 10.1016/0012-1606(81)90311-0. View

5.
Baram J, Chabner B, Drake J, Fitzhugh A, Sholar P, Allegra C . Identification and biochemical properties of 10-formyldihydrofolate, a novel folate found in methotrexate-treated cells. J Biol Chem. 1988; 263(15):7105-11. View